#65 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
I’d be happy to write a clinical summary, but the article text you’ve provided appears to be incomplete—it cuts off at “arguing weed is…” without the substantive content, findings, or specific research being discussed. To provide an accurate and clinically relevant summary for a physician audience, I would need the full article text, including the specific research findings, mechanisms of harm identified, populations affected, and clinical recommendations mentioned. Could you please provide the complete article so I can generate an appropriate clinical summary?
“What concerns me most in my practice is not that cannabis has risks—all medications do—but that we’ve swung from prohibition to a kind of magical thinking where patients believe cannabis is risk-free, when the evidence clearly shows dose-dependent effects on cognition, motivation, and psychiatric stability that we’re only beginning to understand in real populations.”
🧠 While concerns about cannabis safety deserve serious consideration, clinicians should recognize that public health messaging around marijuana involves genuine scientific complexity and evolving evidence that does not yet support blanket conclusions about danger across all uses and populations. The cannabis landscape has shifted dramatically with changing potency levels, delivery methods, and patient demographics, making historical safety data increasingly difficult to apply uniformly to current clinical scenarios. Legitimate concerns about cannabis use in adolescents, during pregnancy, and in individuals with psychosis risk should be distinguished from claims about universal harm, as these distinctions matter for counseling and risk stratification. Healthcare providers would benefit from moving beyond polarized positions to instead have individualized conversations with patients about their specific risk factors, comorbidities, and intended use patterns, while maintaining transparency about areas where evidence remains limited. Given the reality that many patients are already using or considering cannabis despite clinician concerns, a practical approach involves building trust through balanced discussion of both documented harms
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: